Skip to main content

Table 1 Means (± s.d) of the haematological variables for each blood component obtained with every anticoagulant

From: Effects of sodium citrate and acid citrate dextrose solutions on cell counts and growth factor release from equine pure-platelet rich plasma and pure-platelet rich gel

Variable Anticoagulant
  Sodium citrate (SC) ACD-A ACD-B
  Whole blood P-PRP PPP Whole blood P-PRP PPP Whole blood P-PRP PPP
PLT (103/μL) 143.8 (19.4)a,b 390.6 (57.6)c 111.0 (22.6) 137.0 (21.3)a 399.1 (62.8)c 112.6 (23.7) 137.1 (25.4)a 398.5 (48.0)c 111.2 (18.5)
MPV (fL) 3.8 (0.4) 4.1 (0.6)b 3.6 (0.3) 3.8 (0.4) 4.2 (0.6)b 3.7 (0.4) 3.8 (0.4)d 4.2 (0.5)b 3.7 (0.4)
PDW (%) 16.5 (0.5)c 16.8 (0.5)c 17.8 (0.5) 16.3 (0.5)c 16.5 (0.6)c 17.6 (0.7) 16.1 (0.6)c 16.7 (0.6)c 17.8 (0.7)
WBC (103/μL)* 8.4 (1.7)c,d 9.5 (3.0)c 0.1 (0.0) 7.9 (2.0)c,d 9.8 (5.0)c 0.1 (0.0) 8.3 (2.3)e 10.6 (4.0)c 0.1 (0.0)
  1. ACD: acid citrate dextrose (solution-A,-B); P-PRP: pure platelet-rich plasma; PPP: platelet-poor plasma; PLT, platelets; MPV: mean platelet volume; PDW: platelet distribution width; WBC: white blood cells. Lower-case letters represent significant differences between blood components for every independent anticoagulant. Blood components significantly different with a: P-PRP (P <0.001); b: PPP (P <0.05); c: PPP (P <0.001); d: P-PRP (P <0.05); and e: P-PRP PPP (P <0.001); *Data are presented as medians (interquartile range (IR).